Title : Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte function.

Pub. Date : 2003 Jan-Feb

PMID : 12659664






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Either ribavirin (RBV) or cyclophosphamide (CY) can shift an immune response from Th2 toward a Th1 cytokine profile. Ribavirin negative elongation factor complex member C/D Homo sapiens
2 Either ribavirin (RBV) or cyclophosphamide (CY) can shift an immune response from Th2 toward a Th1 cytokine profile. Ribavirin negative elongation factor complex member C/D Homo sapiens
3 RBV is used today mainly to augment interferon-alpha treatment of hepatitis C. RBV shifts an immune response from Th2 toward Th1 more effectively than CY and may be a safe and useful adjuvant for current cancer immunotherapeutic efforts. Ribavirin negative elongation factor complex member C/D Homo sapiens
4 RBV is used today mainly to augment interferon-alpha treatment of hepatitis C. RBV shifts an immune response from Th2 toward Th1 more effectively than CY and may be a safe and useful adjuvant for current cancer immunotherapeutic efforts. Ribavirin negative elongation factor complex member C/D Homo sapiens